company ID Biomedical Corporation of Quebec Asiyah Yu Lin GSK Acquires Influenza Vaccine Manufacturer ID Biomedical Corporation http://www.medicalnewstoday.com/releases/34803.php GlaxoSmithKline plc (NYSE:GSK) announced the completion of the acquisition of ID Biomedical. This follows regulatory clearances of the transaction and adoption of the acquisition agreement by ID Biomedical's shareholders (which occurred on the 16th of November). ID Biomedical becomes a wholly-owned subsidiary of GSK. ...